A Pharmaceutical and Medical Services Company
A Pharmaceutical and Medical Services Company
A Pharmaceutical and Medical Services Company
Our Oman based company was established in 2017 and is built up of well renowned senior pharmacists
The Ibn Al Baitar Medical Company works jointly with ENANA Medical Group in Iraq, a significant provider of pharmaceuticals, medical equipment, and technology to the Iraqi market, supplying both the public and private sectors.
In 2018, we launched Heberprot-P (Recombinant Human Epidermal Growth Factor), a novel product for treating advanced diabetic foot ulcer.
In 2022 we took over the management of Arabi Specialized Hospital and center for eye and ENT (formerly known as Maghrabi Hospital) in Oman
We developed Ibn AL Baitar with the desire to give back to our community and improve the lives of patients suffering from sicknesses that impair their quality of life.
We began this journey by launching Heberprot-P, a Cuban developed innovative medication for diabetic foot ulcers.
As a pharmaceutical and medical services company, is to improve the quality of life of the many affected by illnesses and injuries in our region.
In May 2017, we put together an evaluation to show the effectiveness of the medication at the Royal Hospital in Muscat, Oman.
They began by treating 14 very badly wounded patients, with the majority planned for amputation.
However, over two weeks; the wounds had dramatically granulated showing healthy tissues and recovery for all!
This medication has treated over 160,000 diabetic foot ulcer patients with success.
As a result, it has
reduced patients risk of amputation by
77%.
This medication has treated over 160,000 diabetic foot ulcer patients with success.
As a result, it has
reduced patients risk of amputation by
77%.